Special Issue "Multi-Omics in Cancers and Immune System"
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".
Deadline for manuscript submissions: 15 December 2023 | Viewed by 92
Special Issue Editors
Dr. Jian He
Interests: single-cell multiple-omics analysis; single-cell omics strategies; drug screening
Interests: immune responses; natural killer cells; T cells; HIV; viral emerging diseases
Special Issue Information
Dear Colleagues,
This Research Topic aims to gather cutting-edge research that employs multi-omics techniques in the study of cancers and the immune system. We are seeking contributions that illuminate the molecular mechanisms underlying cancer progression, metastasis, and immune evasion. Additionally, we are interested in investigations into the diversity and functionality of immune cells within the tumor microenvironment, as well as unique insights into other diseases related to the immune system. Furthermore, we encourage research aimed at leveraging these high-resolution data to discover new biomarkers for early disease detection, diagnosis, prognosis, and treatment response.
The Research Topic contents mainly include, but are not limited to:
- Molecular mechanisms of cancer progression and metastasis through multi-omics
- Immune cell diversity and functionality within the tumor microenvironment
- Multi-omics insights into immune system-related diseases
- Biomarker discovery for early disease detection, prognosis, and treatment response
- Translational studies for improved clinical strategies in cancer and immune diseases
In addition to these primary areas of interest, we remain open to any research work that significantly contributes to the field of multi-omics, particularly studies that provide a more nuanced understanding of cellular heterogeneity in cancers and immune system disorders.
Dr. Jian He
Dr. Vincent Vieillard
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immune cell diversity
- tumor microenvironment
- single-cell multi-omics
- immune system-related diseases
- biomarker discovery
